QTMeds

KEPPRA 100 mg/ml

Clinical Description (Database Summary)

(Hérité de KEPPRA 1000 mg) (Hérité de KEPPRA 100 mg/ml) Several case reports of QT prolongation associated with levetiracetam but these studies did not evaluate the comorbidities and comedications to the likelihood of levetiracetam in prolonging QT interval. A study in a pediatric population suggests that levetiracetam has a protective effect against QT prolongation. Nonetheless : French authorities warns us about QT prolongation risks Recently, in 2024, Martyna Janusz et al showed the absence of correlation between LEVETIRACETAM usage and QT prolongation

Scientific Sources / References

https://doi.org/10.1212/WNL.0000000000209177, https://base-donnees-publique.medicaments.gouv.fr/medicament/68876092/extrait#tab-rcp